Status:
COMPLETED
Ultrasound Grayscale Analysis in ARDS covid19
Lead Sponsor:
University of Milan
Conditions:
Muscular Diseases
COVID-19 Acute Respiratory Distress Syndrome
Brief Summary
Recent evidence regarding the novel coronavirus disease 2019 (COVID19) is growing in describing the characteristics of this disease, with main focus on lung morphology. Few data are available regardin...
Detailed Description
Up to 30% of the patients affected by the novel coronavirus disease 2019 (COVID19) may develop an acute respiratory distress syndrome (ARDS), which requires in the majority of patients a respiratory s...
Eligibility Criteria
Inclusion
- \- intubated patients with confirmed infection by SARS COV 2 and diagnosis of ARDS
Exclusion
- age less than 18 years, history of severe chronic obstructive pulmonary disease, pregnancy, failure to perform respiratory muscle ultrasound
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 21 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04863534
Start Date
April 1 2020
End Date
February 21 2021
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST-Santi Paolo e Carlo, San Paolo Hospital
Milan, Italy, 20142